Details
Stereochemistry | RACEMIC |
Molecular Formula | C24H31NO |
Molecular Weight | 349.509 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)C(CC(C)N1CCCCC1)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=SVDHSZFEQYXRDC-UHFFFAOYSA-N
InChI=1S/C24H31NO/c1-3-23(26)24(21-13-7-4-8-14-21,22-15-9-5-10-16-22)19-20(2)25-17-11-6-12-18-25/h4-5,7-10,13-16,20H,3,6,11-12,17-19H2,1-2H3
Molecular Formula | C24H31NO |
Molecular Weight | 349.509 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionCurator's Comment: description was created based on several sources, including:
http://www.druginfosys.com/drug.aspx?drugcode=252&type=1 | doi: 10.1007/978-3-540-68706-1_1823 | Miller, R.L. (2002) "The Encyclopedia of Addictive Drugs", p.130 Retrieved from https://books.google.ru/books?id=G7As-qawdzMC
Curator's Comment: description was created based on several sources, including:
http://www.druginfosys.com/drug.aspx?drugcode=252&type=1 | doi: 10.1007/978-3-540-68706-1_1823 | Miller, R.L. (2002) "The Encyclopedia of Addictive Drugs", p.130 Retrieved from https://books.google.ru/books?id=G7As-qawdzMC
Dipipanone are indicated for the management of moderate to severe pain in medical and surgical conditions in which morphine may be indicated. Dipipanone is related to methadone and can be substituted for assorted opioids. The severe or irreversible adverse effects of Dipipanone, which give rise to further complications, include hypotension, hypotension, hependence, agranulocytosis, ischemic colitis, generalized chorea, hypersensitivity hepatitis. It may interact badly with monoamine oxidase inhibitors, which are substances found in some antidepressants and other medication.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 16 19:58:38 UTC 2022
by
admin
on
Fri Dec 16 19:58:38 UTC 2022
|
Record UNII |
X188638Y2V
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
||
|
NCI_THESAURUS |
C1506
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
||
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
||
|
DEA NO. |
9622
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
856-87-1
Created by
admin on Fri Dec 16 19:58:38 UTC 2022 , Edited by admin on Fri Dec 16 19:58:38 UTC 2022
|
SUPERSEDED | |||
|
M4647
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | Merck Index | ||
|
C007527
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | |||
|
CHEMBL2111157
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | |||
|
C65426
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | |||
|
SUB07215MIG
Created by
admin on Fri Dec 16 19:58:38 UTC 2022 , Edited by admin on Fri Dec 16 19:58:38 UTC 2022
|
PRIMARY | |||
|
27453-70-9
Created by
admin on Fri Dec 16 19:58:38 UTC 2022 , Edited by admin on Fri Dec 16 19:58:38 UTC 2022
|
SUPERSEDED | |||
|
DIPIPANONE
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | |||
|
DTXSID50894759
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | |||
|
X188638Y2V
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | |||
|
465
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | |||
|
207-399-2
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | |||
|
921
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | |||
|
23405
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | RxNorm | ||
|
DB01491
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY | |||
|
467-83-4
Created by
admin on Fri Dec 16 19:58:38 UTC 2022 , Edited by admin on Fri Dec 16 19:58:38 UTC 2022
|
PRIMARY | |||
|
13331
Created by
admin on Fri Dec 16 19:58:39 UTC 2022 , Edited by admin on Fri Dec 16 19:58:39 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |